Cervical Locking Screw Cervical Locking Screw is a spinal implant that is used for the treatment of various spinal conditions. These screws are used to fix other cervical implants in place. Siora Surgicals Pvt. Ltd., an Indian-FDA-approved orthopedic device company manufactures these screws using medical-grade titanium. They are available in diameter sizes of 4.0 mm and lengths ranging from 10 to 30 mm. Siora is also an experienced OEM/contract manufacturing service provider. https://www.siiora.com/product/cervical-locking-screw/

The antibody contract manufacturing market is projected to reach USD 17 billion by 2030 With over 100 therapeutic monoclonal antibodies and antibody-based products in the market, the demand for developing and manufacturing of such products is anticipated to increase beyond the capabilities of innovator companies alone For additional details, please visit https://www.rootsanalysis.com/reports/view_document/antibody-cmo-market/295.html

Advantages of Electronic Contract Manufacturing Contract manufacturing offers a variety of different benefits. The top 4 benefits that come with contract manufacturing include. Visit https://bit.ly/32pdnQW for more info. #electroniccontractmanufacturingservices

The bispecific antibody therapeutics market is estimated to be worth USD 6.9 billion in 2030, predicts Roots Analysis Bispecific antibody therapeutics represent a transformative approach to modern treatment; over the years, this upcoming class of ‘two-target’ artificially engineered drugs have generated significant enthusiasm within the medical science community Roots Analysis is pleased to announce the publication of its recent study, titled, “Bispecific Antibody Market (4th Edition), 2020-2030.” The report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of these therapeutics over the next decade. The study features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. Amongst other elements, the report includes:  A detailed assessment of the current market landscape of drug developers engaged in the development of bispecific antibody therapeutics.  A comprehensive analysis of novel technology platforms that are either currently available or being developed for the generation of bispecific antibody therapeutics.  Detailed profiles of marketed and clinical stage (phase II and phase III) bispecific antibody therapeutics.  Key takeaways from the bispecific antibody therapeutics pipeline.  An analysis of the initiatives of big biopharma players engaged in this domain.  An analysis of recent partnerships and collaboration agreements inked in bispecific antibody therapeutics domain.  A review on the key steps involved and challenges associated with the manufacturing of bispecific antibodies.  A clinical trial analysis of ongoing and planned studies related to bispecific antibody therapeutics.  A review of the key promotional strategies that have been adopted by the developers of the marketed bispecific antibodies.  A discussion on important, industry-specific trends, key market drivers and challenges, under a SWOT framework.  A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)  Target Disease Indication  Autoimmune Disorders  Eye Disorders  Genetic Disorders  Hematological Malignancies  Infectious Diseases  Inflammatory Disorders  Skin Disorders  Mechanism of Action  Cytokines Retargeting / Neutralization  Dual Ligands Blocking  T-cell Retargeting / Activation  Others  Target Antigens  CD3 x CD19  CD30 x CD16A  Factor IXa x Factor X  IL-1α x IL-1β  IL-13 x IL-4  IL-17A x Albumin  IL-17A x IL-17F  Psl x PcrV  TNF-α x HAS  VEGF-A x ANG2  Others  Antibody Format  Asymmetric  Fragments  Symmetric  Others  Key Geographical Region  North America  Europe  Asia-Pacific Transcripts of interviews held with the following senior level representatives of stakeholder companies:  Martin Steiner (Chief Executive Officer, Synimmune)  Ludger Große-Hovest (Chief Scientific Officer, Synimmune)  Jane Dancer (Chief Business Officer, F-Star)  Siobhan Pomeroy (Senior Director, Business Development, Cytom X)  Yinjue Wang (Associate Director, Process Development, Innovent Biologics) Key companies covered in the report  Amgen  Ablynx  AbbVie  Affibody  Affimed  Alphamab  AstraZeneca  Avillion  Chugai Pharmaceuticals  Eddingpharm  GSK  Merck  Merus  Roche  Regeneron Pharmaceuticals  Taisho Pharmaceuticals  Zymeworks For more information please click on the following link: https://www.rootsanalysis.com/reports/view_document/bispecific-antibodies/286.html Other Recent Offerings 1. Global Preventive Vaccines Market, 2020-2030 2. Endocannabinoid System Targeted Therapeutics Market, 2019-2030 3. Antibody Contract Manufacturing Market, 2020-2030 About Roots Analysis Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at [email protected] Contact Information Roots Analysis Private Limited Ben Johnson +1 (415) 800 3415 [email protected] Facebook - https://www.facebook.com/RootsAnalysis LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/ Twitter - https://twitter.com/RootsAnalysis Medium - https://medium.com/@RootsAnalysis Pinterest - https://in.pinterest.com/RootsanalysisPin/_saved/ Quora - https://rootsanalysisinsights.quora.com/

Contract manufacturing of tea | Private Labelling - Sugandh tea Sugandh tea - We have developed expertise in the field of contract manufacturing of tea. We are the leading manufacturer of Darjeeling and Assam healthy tea in India. https://sugandhtea.com/

The “Biopharmaceutical Contract Manufacturing Market (3rd edition), 2019 – 2030” report features an extensive study on the contract service providers within the biopharmaceutical industry An analysis on the recent trends within biopharmaceutical contract manufacturing industry, highlighting various facility and capability expansions. In addition, it provides information on the technology advancements related to biomanufacturing. To order this 750+ page report, please visit this - https://rootsanalysis.com/reports/view_document/biopharma-contract-manufacturing-market-3rd-edition-2019-2030/250.html

Contract manufacturing of tea | Private Labelling - Sugandh tea Sugandh tea - We have developed expertise in the field of contract manufacturing of tea. We are the leading manufacturer of Darjeeling and Assam healthy tea in India. https://sugandhtea.com/